p38 Inhibitor SB203580 sensitizes the resveratrol-induced apoptosis in human lung adenocarcinoma (A549) cells

被引:4
|
作者
Li, Haiyang [1 ]
Wang, Xiaoping [1 ]
Chen, Tongsheng [2 ,3 ]
Qu, Junle [4 ]
机构
[1] Jinan Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510632, Guangdong, Peoples R China
[2] S China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China
[3] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China
[4] Shenzhen Univ, Inst Optoelect, Minist Educ & Guangdong Prov, Key Lab Optoelect Devices & Syst, Shenzhen 518060, Peoples R China
基金
中国国家自然科学基金;
关键词
Resveratrol; SB203580; A549; p38; Apoptosis; Bax; Caspase; FasL; SIGNAL-TRANSDUCTION; PROTEIN; ACTIVATION; PATHWAY; KINASE; BAX; MODULATION; SURVIVAL; MAPK;
D O I
10.1002/jbt.21413
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Based on our recent findings that resveratrol, a natural plant polyphenol found in red grape skins as well as other food products, induces apoptosis via a caspase-independent intrinsic pathway in human lung adenocarcinoma cells, this study is designed to explore whether SB203580, a p38 inhibitor, potentiates the resveratrol-induced apoptosis of human lung adenocarcinoma (A549) cells. We found that pretreatment with SB203580 enhanced the resveratrol-induced apoptosis by accelerating the intrinsic apoptotic pathway including Bax activation, loss of mitochondrial membrane potential, and activation of both caspase-9 and -3. Although treatment with resveratrol alone did not induce caspase-8 activation, cotreatment with both SB203580 and resveratrol not only enhanced FasL cleavage but also activated caspase-8, indicating that the extrinsic apoptotic pathway may be involved in the synergistic effect. Collectively, we for the first time demonstrate that SB203580 synergistically enhances the resveratrol-induced apoptosis by accelerating Bax-mediated intrinsic pathway and initiating extrinsic pathway, suggesting a possible alternative therapeutic strategy for human lung cancer. (c) 2012 Wiley Periodicals, Inc. J Biochem Mol Toxicol 26:251257, 2012; View this article online at . DOI 10.1002/jbt.21413
引用
收藏
页码:251 / 257
页数:7
相关论文
共 50 条
  • [41] P38 MAP kinase is involved in oleuropein-induced apoptosis in A549 cells by a mitochondrial apoptotic cascade
    Cao, Shasha
    Zhu, Xixi
    Du, Linfang
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 95 : 1425 - 1435
  • [42] p38 Mitogen-activated protein kinase inhibitor SB203580 reverses the antianalgesia induced by dextro-morphine or morphine in the mouse spinal cord
    Wu, Hsiang-en
    Sun, Han-Sen
    Cheng, Caleb W.
    Tseng, Leon F.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 550 (1-3) : 91 - 94
  • [43] P38 MAPK Pharmacological Inhibitor SB203580 Alleviates Total Parenteral Nutrition-Induced Loss of Intestinal Barrier Function but Promotes Hepatocyte Lipoapoptosis
    Xiao, Yong-Tao
    Yan, Wei-Hui
    Cao, Yi
    Yan, Jun-Kai
    Cai, Wei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (02) : 623 - 634
  • [44] Anti-ischaemic action of transforming growth factor β-1 in the rat isolated heart is abolished by the p38 MAPK inhibitor SB203580
    Mocanu, MM
    Baxter, GF
    Yellon, DM
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123
  • [45] Effect of P38 MAPK on the apoptosis of human lung adenocarcinoma cell induced by the spider venom
    Guo, Jianwen
    Zuo, Lianfu
    Liu, Jianghui
    Hu, Xiaodong
    Li, Chunyun
    Zhao, Yajuan
    Gao, Li
    THORACIC CANCER, 2010, 1 (02) : 77 - 82
  • [46] The p38 MaPK inhibitor sB203580 abrogates Tumor necrosis Factor-induced Proliferative expansion of Mouse cD4+Foxp3+ regulatory T cells
    He, Tianzhen
    Liu, Shuoyang
    Chen, Shaokui
    Ye, Jingyi
    Wu, Xueqiang
    Bian, Zhaoxiang
    Chen, Xin
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [47] Differential regulation of mast cell cytokines by both dexamethasone and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580
    Koranteng, RD
    Swindle, EJ
    Davis, BJ
    Dearman, RJ
    Kimber, I
    Flanagan, BF
    Coleman, JW
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 137 (01): : 81 - 87
  • [48] P38 mitogen-activated protein kinase inhibitor SB203580 has a bi-directional effect on iNOS expression and NO production
    Lahti, A
    Kankaanranta, H
    Moilanen, E
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 454 (2-3) : 115 - 123
  • [49] Infarct-limiting action of transforming growth factor β1 in isolated rat heart is abolished by the p38 MAPK inhibitor SB203580
    Baxter, GF
    Mocanu, MM
    Yellon, DM
    CIRCULATION, 1998, 98 (17) : 71 - 72
  • [50] Enhancement of anti-inflammatory tendency by SB203580, p38α specific inhibitor, in human fibroblast-like synoviocyte cell line, MH7A
    Han, Seon Kyu
    Jeon, Su jin
    Miyazawa, Keiji
    Yi, Seh yoon
    Yoo, Young Sook
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (11) : 972 - 978